WO2025017533 - EXTENDED RELEASE DRUG-LOADED MICROPARTICLES
National phase entry:
Publication Number
WO/2025/017533
Publication Date
23.01.2025
International Application No.
PCT/IB2024/057044
International Filing Date
19.07.2024
Title **
[English]
EXTENDED RELEASE DRUG-LOADED MICROPARTICLES
[French]
MICROPARTICULES CHARGÉES D'UN MÉDICAMENT À LIBÉRATION PROLONGÉE
Applicants **
FERRING B.V.
Inventors
SEEMANN, Heiko
BJERREGAARD, Simon
JACCOUD, Arnaud Frederic
PRADAL, Julie
Priority Data
63/528,015
20.07.2023
US
Application details
| Total Number of Claims/PCT | * |
| Number of Independent Claims | * |
| Number of Priorities | * |
| Number of Multi-Dependent Claims | * |
| Number of Drawings | * |
| Pages for Publication | * |
| Number of Pages with Drawings | * |
| Pages of Specification | * |
| * | |
| Number of Office Actions | * |
| * | |
International Searching Authority |
EPO
* |
| Recordal of a Change of the Applicant's Name/Address |
Change of Applicant's Name and Address
* |
| Type of Assignment |
The Standard Agent's Assignment
* |
| Applicant's Legal Status |
Legal Entity
* |
| * | |
| * | |
| * | |
| * | |
| * | |
| Entry into National Phase under |
Chapter I
* |
| Patent Delivery |
Send the Letters Patent by Courier
* |
| Translation |
|
* The data is based on automatic recognition. Please verify and amend if necessary.
** IP-Coster compiles data from publicly available sources. If this data includes your personal information, you can contact us to request its removal.
Quotation for National Phase entry
| Country | Stages | Total | |
|---|---|---|---|
| China | Filing, Examination, Granting | 5048 | |
| EPO | Filing, Examination, Granting | 79133 | |
| Japan | Filing, Examination, Granting | 4478 | |
| South Korea | Filing, Examination, Granting | 6619 | |
| USA | Filing, Examination, Granting | 30990 |
Total:
126,268
The term for entry into the National Phase has expired. This quotation is for informational purposes only
Contact Us
Abstract[English]
Described are extended release drug-loaded microparticles, pharmaceutical compositions comprising them, methods of making them, and therapeutic methods using them.[French]
Sont décrits des microparticules chargées d'un médicament à libération prolongée, des compositions pharmaceutiques les comprenant, leurs procédés de fabrication, et des procédés thérapeutiques les utilisant.